Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Carna Biosciences Inc
4572Current price
332 JPY
+22.17 JPY (+7.10%)
Last closed
300 JPY
Company
www.carnabio.com
ISIN
JP3220550002
Sector
Healthcare
Industry
Biotechnology
Exchange
Tokyo Stock Exchange
Capitalization
6 142 786 497 JPY
Yield for 12 month
-60.90 %
1Y
3Y
5Y
10Y
15Y
4572
Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan. Its products include kinase proteins, substrates, kinase protein assay kits, and stable cell lines, as well as biotinylated kinases. The company also offers profiling, NanoBRET TE intracellular kinase cell-based assay, protein detection and interaction, live-cell kinase assay, and tyrosine kinase cell-based assay services. It also focuses on developing products for the treatment of various diseases, such as AS-0141, an orally bioavailable small molecule inhibitor of CDC7 kinase that is in preclinical trials to treat cancer; AS-0871, a small molecule drug for inflammatory and immune disorders, which is in Phase 1 clinical trials; and AS-1763, an orally bioavailable and non-covalent inhibitor for the treatment of chronic lymphocytic leukemia and other B cell malignancies that is in preclinical trials. The company has collaborations with Johnson & Johnson, Sierra Oncology, Sumitomo Dainippon Pharma, Gilead Sciences, and BioNova Pharmaceuticals. Carna Biosciences, Inc. was incorporated in 2003 and is based in Kobe, Japan. Address: BMA, 1-5-5 Minatojima-Minamimachi, Kobe, Japan, 650-0047
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
523 856.7 JPYP/E ratio
–Dividend Yield
–Current Year
+1 629 124 541 JPY
Last Year
+1 389 507 556 JPY
Current Quarter
+135 040 242 JPY
Last Quarter
+181 229 920 JPY
Current Year
+1 453 482 631 JPY
Last Year
+1 217 616 306 JPY
Current Quarter
+99 008 608 JPY
Last Quarter
+134 467 081 JPY
Key Figures 4572
1 year
3 years
5 years
10 years
EBITDA
-1 459 398 360 JPY
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-26.03 %
PEG Ratio
–
Return On Equity TTM
-46.68 %
Wall Street Target Price
523 856.7 JPY
Revenue TTM
1 403 787 914 JPY
Book Value
147.31 JPY
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-18.5 %
Dividend Yield
–
Gross Profit TTM
1 217 417 840 JPY
Earnings per share
-78.21 JPY
Diluted Eps TTM
-78.21 JPY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-107.78 %
Dividend Analytics 4572
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 4572
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
100:1
Payout Ratio
–
Last Split Date
26.12.2013
Dividend Date
–
Stock Valuation 4572
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
2.3616
Price Sales TTM
4.3759
Enterprise Value EBITDA
-25.2305
Price Book MRQ
1.972
Financials 4572
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 4572
For 52 weeks
285.57 JPY
877.74 JPY
50 Day MA
365.11 JPY
Shares Short Prior Month
–
200 Day MA
410.82 JPY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart